Tumor volume reduction rate measured during adaptive definitive radiation therapy as a potential prognosticator of locoregional control in patients with oropharyngeal cancer-Reference-Cited by-同舟云学术

Tumor volume reduction rate measured during adaptive definitive radiation therapy as a potential prognosticator of locoregional control in patients with oropharyngeal cancer

Published:2013-06-18 Issue:4 Volume:36 Page:499-504
ISSN:1043-3074
Container-title:Head & Neck
language:en
Short-container-title:Head Neck

Author:

Lee Hyebin¹,Ahn Yong Chan¹,Oh Dongryul¹,Nam Heerim¹²,Kim Young Il¹,Park Su Yeon¹

Affiliation:

1. Department of Radiation Oncology; Samsung Medical Center; Seoul Korea

2. Department of Radiation Oncology; Samsung Kangbuk Hospital; Sungkyunkwan University School of Medicine; Seoul Korea

Publisher

Wiley

Subject

Otorhinolaryngology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hed.23328/fullpdf

Reference19 articles.

1. Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience;Brockstein;Ann Oncol,2004

2. Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison;Soo;Br J Cancer,2005

3. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma;Denis;J Clin Oncol,2004

4. Measures of response: RECIST, WHO, and new alternatives;Jaffe;J Clin Oncol,2006

5. Carcinoma of the tonsillar fossa: prognostic factors and long-term therapy outcome;Perez;Int J Radiat Oncol Biol Phys,1998

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk stratification of LA‐NPC during chemoradiotherapy based on clinical classification and TVRR;Cancer Medicine;2024-02

2. Automated tracking of morphologic changes in weekly magnetic resonance imaging during head and neck radiotherapy;Journal of Applied Clinical Medical Physics;2023-05-05

3. Retrospective Clinical Evaluation of a Decision-Support Software for Adaptive Radiotherapy of Head and Neck Cancer Patients;Frontiers in Oncology;2022-06-30

4. Does Tumor Volume Have a Prognostic Role in Oropharyngeal Squamous Cell Carcinoma? A Systematic Review and Meta-Analysis;Cancers;2022-05-17

5. Criteria for Verification and Replanning Based on the Adaptive Radiotherapy Protocol “Best for Adaptive Radiotherapy” in Head and Neck Cancer;Life;2022-05-12